Investing Profile
Katie Ellias
Your Intro Paths to Katie Ellias
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Katie Ellias on
cbCurrent Investing Position
T1D Fund Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
10
Katie Ellias is on these Sector & Stage Rankings
Medical Devices (Seed)Pharmaceuticals (Seed)Education (Seed)Digital Health (Seed)Health & Hospital Services (Seed)BioTech (Seed)Health IT (Seed)Pharmaceuticals (Series A)Medical Devices (Series A)Education (Series A)Digital Health (Series A)BioTech (Series A)Health & Hospital Services (Series A)Health IT (Series A)Medical Devices (Series B)Pharmaceuticals (Series B)Education (Series B)Digital Health (Series B)Health & Hospital Services (Series B)BioTech (Series B)Health IT (Series B)Boston / New England
Katie Ellias's Investments On Record (7)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Veralox Therapeutics | Series UnknownJun 2023$24M Series AJun 2021$17M SeedSep 2019$5M | $46M |
Jaguar Gene Therapy | Series UnknownMar 2022 | $140M |
Biolinq | Series BNov 2021$100M Series AMar 2019$5M | $110M |
DiogenX | SeedJun 2020$5M | $42M |
i2o Therapeutics | SeedApr 2020$4M | $4M |
Repertoire Immune Medicines | Series UnknownMar 2020 | $210M |
IMTherapeutics | Series AOct 2019$10M | $10M |
Investors who invest with Katie Ellias